NEURO2022

Presentation information

Print

Symposia

[1S03m] Drug discovery based on novel therapeutic target to neuropsychiatric disorders in interdisciplinary research

Thu. Jun 30, 2022 9:00 AM - 11:00 AM Room 3 (Conference Building B1 (Okinawa Convention Center))

Chair: Daisuke Ibi, AKIHIRO MOURI

[1S03m-03] Validity of serotonin 5-HT2A receptor in the lateral septum as a therapeutic target of stress-related disorders

*Daisuke Ibi1 (1. Dept Chem Pharmacol, Meijo Univ, Nagoya, Japan)

Keywords:Psychedelics , Depression, Serotonin 5-HT2A receptor, Lateral septum

Abstract password authentication.
A password is required to view the full text of the abstract. Please enter the following password.

PW: Neuro2022

Password